ASCO: Shorter RT Course OK in Mid-Risk Prostate Ca (CME/CE)

(MedPage Today) -- Similar survival, long-term toxicity as conventional radiotherapy
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news